参考文献:1.Brabin L, et al. Current issues in adolescent immunization. Vaccine. 2008;26(33):4120–34.CrossRef PubMed 2.Resnick MD, et al. Seizing the opportunities of adolescent health. Lancet. 2012;379(9826):1564–7.CrossRef PubMed 3.Broder KR, et al. Adolescent immunizations and other clinical preventive services: a needle and a hook? Pediatrics. 2008;121(Suppl 1):S25–34.CrossRef PubMed 4.Humiston SG, et al. Health care provider attitudes and practices regarding adolescent immunizations: a qualitative study. Patient Educ Couns. 2009;75(1):121–7.CrossRef PubMed 5.Middleman AB. Coordinating the delivery of vaccinations and other preventive health care recommendations for adolescents. Prev Med. 2011;53(Suppl 1):S22–8.CrossRef PubMed 6.Kharbanda EO, et al. The role of human papillomavirus vaccination in promoting delivery of other preventive and medical services. Acad Pediatr. 2011;11(4):326–32.CrossRef PubMed 7.Delaporte E, Wyler Lazarevic CA, Iten A, Sudre P. Large measles outbreak in Geneva, Switzerland, January to August 2011: descriptive epidemiology and demonstration of quarantine effectiveness. Euro Surveill. 2013;18(6). 8.Jeannot E, et al. Evolution of the immunization coverage of 13 to 14 year-old adolescents in Geneva between four years. Sante Publique. 2009;21(6):605–11.PubMed 9.Lang P, et al. The Swiss National Vaccination Coverage Survey, 2005–2007. Public Health Rep. 2011;126(Suppl 2):97–108.PubMed PubMedCentral 10.Jeannot E, et al. Facteurs associés à la vaccination HPV chez les jeunes filles de 13 à 14ans dans le canton de Genève, Suisse. Revue d’Épidémiologie et de Santé Publique. 2013;61(6):513–8.CrossRef PubMed 11.Genève HUG. Au coeur des HUG: d’une année à l’autre. Rapport d’activités. Geneva, Switzerland: University Hospitals; 2013. p. 26–8. 12.Vaccine: Immunization surveillance, assessment and monitoring (World Health Organization). 2013. Available from http://www.who.int/immunization_monitoring/data/data_subject/en/index.html . Accessed 7 Jan 2014. 13.Jeannot E, Sudre P, Chastonay P. HPV vaccination coverage within 3 years of program launching (2008–2011) at Geneva State. Switzerland: Int J Public Health; 2012. 14.Lang P, Hatz Ch PU. Couverture vaccinale des enfants âgés de 2, 8 et 16 ans en Suisse, 2008–2010. Bull OFSP. 2012;40:681–6. 15.Meynard A, et al. Immunization and preventive care for young people in Switzerland. Rev Med Suisse. 2012;8(345):1261–5.PubMed 16.Adolescence: a second chance to tackle inequities. Lancet. 2013;382(9904):1535.
1. Unité Santé Jeunes, Division of General Pediatrics, Department of Pediatrics, University Hospitals, 87 Bvd de la Cluse, 1211, Geneva, Switzerland 2. Nyon, Switzerland 3. Faculty of Medicine, Institute of Social and Preventive Medicine, University of Geneva, Geneva, Switzerland 4. Department of Public Instruction, Geneva School Health Service, Geneva, Switzerland 5. Faculty of Medicine, University of Geneva, Geneva, Switzerland
刊物主题:Public Health; Sociology, general; Private International Law, International & Foreign Law, Comparative Law;
出版者:Springer US
ISSN:1557-1920
文摘
Adolescent vaccination coverage is very variable in European countries and data are scarce. The aim of this study was to assess immunization status and analyze potential variations according to sociodemographic variables in a youth clinic in Geneva, Switzerland. Immunization status was assessed retrospectively: Tetanus (number of doses or in absence of data tetanus antibodies) and measles as indicators of childhood coverage as well as hepatitis B and human papillomavirus. All new patients (N = 390) of Geneva University Hospital’s youth clinic were included between January 2010 and June 2011. Vaccine coverage was low for all vaccines regardless of sex or origin. 89 % of young people tested (mostly recent immigrants with no available data) had tetanus antibodies indicating adequate childhood immunization but hepatitis B and HPV coverage was low especially in recent immigrants. Systematic assessment allows better adolescent vaccine coverage and can improve safety by avoiding unnecessary dosis.